# Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID

> **NCT06597396** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 46 (actual)

## Conditions studied

- Post-COVID Condition
- Fatigue Symptom

## Interventions

- **DRUG:** Abrocitinib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06597396
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-27
- **Primary completion:** 2026-03-27
- **Final completion:** 2026-09-30
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06597396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06597396, "Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06597396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*